Pancreatic Stent for Preventing Pancreatitis After Surgery

Does Pancreatic Stent Decrease the Risk of Pancreatitis After Pancreatic Sphincterotomy for Difficult Cannulation?

Recruiting N/A Interventional Study
Endoscopic Retrograde Cholangiopancreatography
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 100
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
268 (estimated)
Sponsor
Helsinki University Central Hospital · Other
Who this trial is looking for

This trial is looking for patients who are having a specific procedure called endoscopic retrograde cholangiopancreatography (ERCP). It compares patients who will receive a small tube called a pancreatic stent to those who will not, to see if it reduces the risk of pancreatitis after the procedure.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have a naïve papilla
  • I need common bile duct cannulation
  • I am having an ERCP procedure

You may not be able to join if

  • I am under 18 years old
  • I have acute pancreatitis
  • I do not consent to participate in the study

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of the study is to compare the risk of PEP after pancreatic sphincterotomy performed for difficult cannulation in a group of patients with and in a group of patients without placement of a prophylactic pancreatic stent. The definition of difficult cannulation is defined according to the literature.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Consecutive patients with naïve papilla presenting to ERCP with indication of common bile duct (CBD) cannulation will be considered to the study. Exclusion Criteria: * Exclusion criteria are age below 18 years, acute pancreatitis and no consent to the study.
Contacts

Andrea Tenca, MD, PhD

+358408484955

ante14@hotmail.it

CONTACT